Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug.
Original Article: Study tests accuracy of laboratory-developed cancer tests and FDA-approved companion diagnostics
NEXT ARTICLE